Delekate, Andrea

NLRP3 is activated in Alzheimer’s disease and contributes to pathology in APP/PS1 mice

Heneka, M. T., Kummer, M. P., Stutz, A., Delekate, A., Schwartz, S., Vieira-Saecker, A., Griep, A., Axt, D., Remus, A., Tzeng, T.-C., et al. (2013) · Nature

Inflammasome and immune disordersAlzheimer's disease research and treatments

Cited by 2,898

Inhibition of Stat3‐mediated astrogliosis ameliorates pathology in an Alzheimer's disease model

Reichenbach, N., Delekate, A., Plescher, M., Schmitt, F., Krauss, S., Blank, N., Halle, A., & Petzold, G. C. (2019) · EMBO Molecular Medicine

Alzheimer's disease research and treatmentsNeuroinflammation and Neurodegeneration Mechanisms

Cited by 343

Metabotropic P2Y1 receptor signalling mediates astrocytic hyperactivity in vivo in an Alzheimer’s disease mouse model

Delekate, A., Füchtemeier, M., Schumacher, T., Ulbrich, C., Foddis, M., & Petzold, G. C. (2014) · Nature Communications

Adenosine and Purinergic SignalingAlzheimer's disease research and treatments

Cited by 332

P2Y1 receptor blockade normalizes network dysfunction and cognition in an Alzheimer’s disease model

Reichenbach, N., Delekate, A., Breithausen, B., Keppler, K., Poll, S., Schulte, T., Peter, J., Plescher, M., Hansen, J. N., Blank, N., et al. (2018) · Journal of Experimental Medicine

Alzheimer's disease research and treatmentsAdenosine and Purinergic Signaling

Cited by 131

Sodium Fluctuations in Astroglia and Their Potential Impact on Astrocyte Function

Felix, L., Delekate, A., Petzold, G. C., & Rose, C. R. (2020) · Frontiers in Physiology

Neuroscience and Neuropharmacology ResearchIon Transport and Channel Regulation

Cited by 38